drugset / Trial / NCT01149785

Estimation Of Effect Of Ketoconazole On Pharmacokinetics Of Crizotinib In Healthy Volunteers

NCT01149785

Phase 1 Completed 15 enrolled Pfizer
Non-randomizedCrossoverOpen-label

Summary

The purpose of this study is to estimate the effect of multiple doses of ketoconazole on the single dose pharmacokinetics of crizotinib in healthy volunteers.

Timeline

Start
2010-07
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Crizotinib Small molecule 150 mg Oral
Subject Ketoconazole Small molecule 200 mg Oral

Indications

No indication recorded.